The growth hormone-insulin like growth factor axis in pregnancy
Date
2021
Authors
Kaur, H.
Muhlhausler, B.S.
Roberts, C.T.
Gatford, K.L.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Journal of Endocrinology, 2021; 251(3):R23-R39
Statement of Responsibility
Harleen Kaur, Beverly S Muhlhausler, Claire T Roberts and Kathryn L Gatford
Conference Name
Abstract
The growth hormone (GH)-insulin-like growth factor (IGF) axis is one of the main drivers of mammalian growth and development. Pituitary secretion of GH is pulsatile and under positive and negative hypothalamic control, as well as stimulation from gastric-secreted acyl-ghrelin. GH has anabolic and metabolic effects both directly via the GH-receptor (GHR) and indirectly via stimulation of IGF1 production at multiple target tissues. In this review, we describe the major changes to this axis during pregnancy, with increasing GH abundance in the maternal circulation across multiple species. This stimulates secretion of IGFs, whose bioavailability is also increased by proteolytic cleavage of their circulating binding proteins during pregnancy. These changes in turn induce maternal metabolic adaptations to pregnancy and promote placental function and fetal growth, as does exogenous GH or IGF treatment in animal models of normal and compromised pregnancy. Finally, we explore alternative approaches to enhance maternal GH abundance during pregnancy to promote maternal adaptations, placental function and hence fetal growth.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© 2021 Society for Endocrinology Published by Bioscientifica Ltd.